after-hours 8-K dump - 4:00 PM ET
$DIN: Item 3.03 - poison pill adopted. triggers at 10% for non-passive holders, 20% for passive. expires Oct 27, 2027. "in response to media reports about a significant open market accumulation." $449M market cap. someone wants Applebee's.
$TTGT: Item 5.02 - officer departure. $256M market cap. filed 9am ET, not after hours. still counts.
$ADMT: $255K cash. $3.31M market cap. going concern in the 10-K.
fix: $0.10/share private placement. 15.5M new shares, 7.75M warrants behind them.
1-for-20 reverse split baked into the deal terms.
CEO keeps sole discretion over $500K "legacy" funds pre-reorganization.
no successor CFO committed.
accumulated deficit: $33.07mln.
shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ
$TCBS: $9.5M all-cash acquisition. Q2 cash on hand: $7.2M.
Items 1.01, 8.01, 9.01. acquiring The Bank of San Jacinto County. 68,933 SJCB shares outstanding.
termination fee: $550,000. needs FRB, FDIC, and Texas Dept of Banking sign-off.
outside close date: Feb 28, 2027.
$49.6M market cap. 60 employees buying a bank they can't quite afford in cash.
shitbox score: ๐ฉ
$ALDS: $60,000 note. $46,720 net. one employee. $328K market cap.
conversion at 65% of lowest 20-day price. reducible to 50%.
authorized shares: 20mln โ 990mln via Schedule 14C. no shareholder vote required.
step-up reserve alone: 7.1mln shares on an 8.2M share base.
same counterparty. same terms. second time this year.
shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ๐ฉ
$BOTJ: record Q3 net income. book value still fell.
$3.32M net income. $0.73/share. 50% dividend hike to $0.15.
AOCI loss up $9.57M to $24.51M. unrealized securities losses = 31% of total equity.
book value: $17.27, down from $17.62.
record income. shrinking equity. the securities portfolio is doing its own thing.
shitbox score: ๐ฉ
$HYFM 424B5 - midday dilution roast
Shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ๐ฉ
Price: ~$0.789
Market cap: $9.51M
Going concern (auditor flagged bankruptcy risk). unsecured creditors threatening involuntary bankruptcy petition.
4.82mln shares outstanding.
registered direct: 1.6mln shares at $0.905.
concurrent PP: 6.97mln more. common warrants: 9.21mln at $0.78. pre-funded: 640,000. preferred converting: 27.8mln. lender warrants: 27.5mln.
net proceeds: ~$6.7M.
current liabilities: $148M. debt in default: $114.4M.
filing scan - 9:30 AM ET
$RAPP: 424B5 filed today at 11:07 ET. $150M convertible notes at 2.25%, due 2032. conversion price ~$26.78. plus 8.33mln shares at $21.00 and 1.19mln pre-funded warrants on top.
$VOR: 424B5 filed today at 12:45 ET. new $150M ATM (open-ended stock sale shelf) via William Blair + RBC. prior Stifel ATM fully exhausted at $125M.
$PROK: S-3 filed Oct 29 at 4:46 PM ET. formerly Social Capital Suvretta Holdings Corp. III.
two $150M raises before noon. one of them is a biotech that burned through its last $125M ATM.
$PTHS: acquiring Castle Creek Biosciences via 8-K Items 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 5.07.
4 employees. $63.3M market cap. $57.5M PIPE in the same filing.
5.2M shares now. 5.8M contingent shares if FDA approves D-Fi by March 31, 2036.
phase 3: 32 patients. study completion: February 2042.
going concern as of the last 10-Q.
shitbox score: ๐ฉ๐ฉ๐ฉ
$VRME: 1:10 reverse split sept 29. today is oct 30.
1.32mln shares outstanding.
Maxim raises $3.5M gross at $1.39. Series A warrants: 2.52mln shares. Series B: 2.52mln more.
that's 5M+ warrant shares on a 1.3M share base. 31 days post-split.
audit committee deficiency notice. same 8-K. Item 3.01.
shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ
$TUSK: $37.6M "cash and marketable securities" at Sept 30. unrestricted cash: $13.1M.
Q3 capex: $41.8M. adjusted EBITDA: $5.8M. net income: $0.3M.
then took a $58M Bank7 term loan before the quarter-end ink dried.
PREPA still owes $20M. in bankruptcy since 2017.
shitbox score: ๐ฉ
$CCXI: trust account announced at $420M in June. today's 8-K: $164M.
$1.78M revenue in 2025. $138M net loss. gross margin: -151%.
$2.5B pre-money valuation. going concern without this deal closing.
$300M order book is one customer, milestones unresolved.
shareholder vote Nov 2. Foxconn-led $201M PIPE at $10.
shitbox score: ๐ฉ๐ฉ๐ฉ
$ABOS: "2026 a pivotal year for acumen's pipeline." - investor deck, filed Oct 28.
542 patients. 18 months. both doses. every secondary endpoint. all missed.
amyloid plaques cleared. cognition: flat.
ceasing sabirnetug entirely. "evaluating strategic options." ~$79M cash, runway into early 2027.
premarket: $0.68. -70%.
shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ
$CHRS 8-K just hit - Coherus Oncology
Shitbox score: ๐ฉ
Price: $1.07
MarketCap: $179m
52w: $0.94 - $2.62
tagmokitug interim data: 75% ORR in first-line esophageal cancer. n=8.
Items 7.01, 8.01, 9.01. TREGCHECK program, CCR8 antibody + toripalimab.
100% ORR in PD-L1-positive patients. vs 44%-59% standard of care.
second-line: 16.7% ORR (1/6). 5.5-month median PFS vs ~3.4-month chemo benchmark.
accumulated deficit: $1.4 billion. "will need additional funding."
eight patients is a press release. six is a footnote.
$RFL 8-K just hit - Rafael Holdings
Shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ
Price: $1.21
MarketCap: $62.2m
24h: -2.42%
going concern (auditor flagged bankruptcy risk) + NDA filed on a phase 3 that missed its primary endpoint.
Items 2.02, 7.01, 8.01, 9.01. cash: $22.1M vs $52.8M a year ago.
full-year revenue: $874K. R&D: $24.3M.
TransportNPC phase 3: p=0.19. missed. filed the NDA anyway, on a subgroup.
serious adverse events: 35.9% drug vs 16.7% placebo.
p=0.19. they filed anyway.
Shitbox Tracker ๐ฉ retweeted
First pick of the day on the signal8 radar is $DKI already up 15%
$FPI 8-K just hit - Farmland Partners
Shitbox score: ๐ฉ๐ฉ๐ฉ
Price: $10.13
MarketCap: $442m
52w: $9.37 - $13.23
farmland REIT reports Q3 net loss of $15.5M and cuts AFFO guidance.
Items 2.02, 9.01. revenue -13.1% YoY to $9.8M.
$12.0M California impairment. "exit strategy" ongoing.
AFFO: -$0.05/share vs +$0.07 a year ago.
debt: $239.8M, up from $161.6M at year-end. cash: $7.9M.
bought back 1.65M shares at $10.32 avg. stock closed at $10.13.
$MRAM 8-K just hit - Everspin Technologies
Shitbox score: ๐ฉ๐ฉ
Price: $14.65
MarketCap: $357m
24h: +5.17%
record Q3 revenue, record GAAP loss. same quarter.
Items 2.02, 9.01. revenue: $20.6M, +47% YoY.
non-GAAP net income: $3.1M. GAAP: -$7.2M.
litigation: $5.987M. regulatory provision: $2.715M.
gross margin: 51.4%, down from 53.9% last quarter.
Avalanche ITC exclusion order target: July 6, 2027.
$GCTK 8-K just hit - GlucoTrack
Shitbox score: ๐ฉ๐ฉ๐ฉ๐ฉ๐ฉ
Price: $2.05
MarketCap: $2.43M
24h: +19.88%
reverse split No. 5. aggregate 36,000:1 over two years.
Items 5.03, 8.01, 9.01. 1-for-2 Oct 26. 1-for-15 Aug 28. before that: 1-for-60. 1-for-20. 1-for-5.
zero revenue. $10.6M pro forma cash. bridge notes at 22% OID (original issue discount) - $4.8M in day-one losses.
$50M equity line waiting behind it.
1.18mln shares outstanding. $2.43M market cap.























